NCT03518814View on ClinicalTrials.gov

Quality of Life in Patients With Multimetastatic Melanoma Currently in Remission (QUALM)

CompletedOBSERVATIONAL
Enrollment

40

Participants

Timeline

Start Date

April 9, 2018

Primary Completion Date

June 5, 2018

Study Completion Date

June 5, 2018

Conditions
Melanoma (Skin) Stage IVRemission
Interventions
OTHER

Questionnaires

FACT-M (Functional Assessment of Cancer Therapy - Melanoma) questionnaire, MOS SF (medical outcome study short form) -36 questionnaire

Trial Locations (2)

59020

Lille Catholic Hospitals, Lille

59037

CHRU Lille, Lille

All Listed Sponsors
collaborator

University Hospital, Lille

OTHER

lead

Lille Catholic University

OTHER

NCT03518814 - Quality of Life in Patients With Multimetastatic Melanoma Currently in Remission (QUALM) | Biotech Hunter | Biotech Hunter